Study: Myo-inositol may lower gestational diabetes risk

01/31/2013 | Reuters

Taking myo-inositol supplements may reduce the likelihood of gestational diabetes among pregnant women at risk for the condition, according to a small study in Diabetes Care. Data on 220 pregnant women with a family history of type 2 diabetes showed 6% of those who took myo-inositol supplements in addition to folic acid developed gestational diabetes, compared with 15% of those only given folic acid.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC